Frank Reynolds, Mba/mse/ms

Biography

Frank invented the NeuroScaffold™, the first treatment to restore function in humans after a traumatic spinal cord injury. In 2014, Frank won a life-time achievement award for curing paralysis from the National Spinal Injury Association. Frank succeeds for obvious reasons, the proper core competencies. Called the “Steve Jobs” of Life Sciences by globally renowned scientists, Frank is the most inventive CEO in Pharma since 2005. He is a co-inventor on over 50 biomaterials based and neurologically focused patent applications. His research has been published in the Journal of Biomaterials and the Journal of Neuroscience: Methods. Mr. Reynolds was featured in the March 2010 and October 2009 issues of Inc. Magazine. He was awarded the 2010 Irish Life Science 50 Award by the President of Ireland, Mary McAleese. Mr. Reynolds won the American Spinal Injury Association’s “2011 David F Apple Award for Excellence in Publishing” in spinal cord injury rehabilitation research. Frank Reynolds co-founded PixarBio Corporation to invent, research and develop biologics, drugs, and devices for a range a neurological conditions. Since September 2013, pain, spinal cord injury, epilepsy, and Parkinson’s disease are a prime focus of his research. As a neuroscientist, engineer and entrepreneur Frank invents his own neurological products and he recruits the teams to commercialize his patents and trade secrets. Frank is the only CEO in Pharma with relevant education and optimized subject matter expertise and core competencies to succeed in the Neuro-Pharma industry. Frank’s competencies in neuroscience, spinal-cord neurosurgery, drug discovery, drug delivery, US FDA Regulatory Affairs, Clinical Studies, cGMP Manufacturing, Patents, Intellectual Property, GAAP, SEC, Financial Analysis, MIS, Serialization, HR, Process Engineering, all combined led to miraculous breakthrough for paralyzing spinal cord injury, the NeuroScaffold™. Frank won the IABCN 2015 “Taoiseach Award” or Prime Minister’s Award for Leadership, presented by Anne Anderson, Ireland Ambassador to the USA. Formal education at MIT, Harvard, Wharton, Univ. of Penn Engineering, St. Joseph’s, Temple University, Chestnut Hill College, Rider University and other universities provided Frank with perfect education to develop new treatments for neurological disease. Frank serves on the Board of Directors of Chestnut Hill College. 

Research Interest

He is interested in neuroscience and neurosurgery.